CDC study confirms vaccination’s greater protection against COVID-19 compared to prior infection and natural immunity

Aug 06, 2021 - 08:07 AM
cdc-update

The Centers for Disease Control and Prevention today released a study confirming the comparative effectiveness of COVID-19 vaccines versus natural immunity, including immunity gained from prior SARS-CoV-2 infection. Researchers found that, among hundreds of Kentucky residents with previous infections through June 2021, those who were unvaccinated had 2.34 times the odds of reinfection compared with those who were fully vaccinated. CDC says the research suggests that among people who have had COVID-19 previously, getting fully vaccinated provides additional protection against reinfection.

A second CDC study, published concurrently, shows the extent to which vaccines prevented COVID-19-related hospitalizations among the highest risk age groups.
 

Related News Articles

Headline
CMS Administrator Oz and Deputy Administrator Brillman discuss agency’s focus on innovation, reducing waste
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…